Pro-Dex, Inc. Announces Plans For Rights Offering To Shareholders

      Pro-Dex, Inc. Announces Plans For Rights Offering To Shareholders

PR Newswire

IRVINE, Calif., Dec. 17, 2013

IRVINE, Calif., Dec. 17, 2013 /PRNewswire/ --Pro-Dex, Inc. (NasdaqCM: PDEX)
today announced that it has filed a Registration Statement on Form S-3 with
the Securities and Exchange Commission (the "SEC") for a rights offering to
existing holders of its common stock. Upon completion of the rights offering,
the Company expects to receive gross proceeds of approximately $3,000,000
before expenses, subject to the Company's right to reduce the rights offering
in order to preserve certain of the Company's tax attributes, such as net
operating loss carry forwards. The Company has received a standby commitment
from AO Partners, LLC and Farnam Street Capital, Inc. (collectively the
"Standby Purchasers"). Nicholas J. Swenson, a director of the Company, is the
Managing Member of AO Partners, LLC. Raymond E. Cabillot, a director of the
Company, is Chief Executive Officer and a director of Farnam Street Capital,
Inc. The Standby Purchasers have agreed to purchase any and all shares of
common stock that are not subscribed for by shareholders in connection with
the rights offering up to an aggregate amount of $3 million, subject to the
Company's right to reduce the number of shares purchased by the Standby
Purchasers in order to preserve the above-referenced tax attributes.


The rights offering will be made through the Company's distribution to its
existing shareholders of non-transferable subscription rights to purchase
their pro rata portion of newly issued shares of the Company's common stock.
The subscription price has not yet been determined but is expected to be based
on a percentage discountof the closing market price of the Company's common
stock, as reported by the NASDAQ Capital Market, on the latest practicable
date prior to the launch of the rights offering. The record date for the
distribution of the rights and the dates for both the subscription period and
the expiration of the rights offering will be included in the final prospectus
that will be filed with the SEC. The purpose of this rights offering is to
raise equity capital in a cost-effective manner that gives all of the
Company's existing shareholders the opportunity to participate on a pro rata
basis. The Company intends to use the net proceeds from the rights offering to
pursue strategic opportunities that may present themselves from time to time
or, if not used to pursue strategic opportunities, for working capital and
general corporate purposes, including to fund ongoing research and development
and product initiatives. Also, to the extent net proceeds of the rights
offering are not deployed, some of the funds may be invested in accordance
with the terms of the Company's Surplus Capital Investment Policy.

A Registration Statement relating to these securities has been filed with the
SEC but has not yet become effective. The securities may not be sold nor may
offers to buy be accepted prior to the time the Registration Statement is
declared effective. A copy of the prospectus forming a part of the
Registration Statement may be obtained free of charge at the website
maintained by the SEC at or by contacting the Company at (949)
769-3200. The rights will be issued to holders of the Company's common stock
as of a record date, which has yet to be determined. The Company will provide
notice of the record date in the future at such time as it is determined. This
press release shall not constitute an offer to sell or the solicitation of an
offer to buy nor shall there be any sale of these securities in any
jurisdiction in which such offer, solicitation or sale would be unlawful prior
to the registration or qualification under the securities laws of any such

About Pro-Dex, Inc.:

Pro-Dex, Inc., with operations in California and Oregon, specializes in the
design, development and manufacture of powered rotary drive surgical and
dental instruments used primarily in the orthopedic, spine, maxocranial facial
and dental markets. Its OMS division designs and manufactures embedded motion
control systems serving the medical, dental, semi-conductor and scientific
research markets. Pro-Dex's products are found in hospitals, dental offices,
medical engineering labs, scientific research facilities and high tech
manufacturing operations around the world. For more information, visit the
Company's website at

Statements herein concerning the Company's plans, growth and strategies, as
well as statements concerning the rights offering, may include
'forward-looking statements' within the context of the federal securities
laws. Statements regarding the Company's future events, developments and
future performance, as well as management's expectations, beliefs, plans,
estimates or projections relating to the future, are forward-looking
statements within the meaning of these laws. The Company's actual results may
differ materially from those suggested as a result of various factors.
Interested parties should refer to the disclosure concerning the operational
and business concerns of the Company set forth in the Company's filings with
the Securities and Exchange Commission.

SOURCE Pro-Dex, Inc.

Contact: Harold A. Hurwitz, Chief Executive Officer, (949) 769-3200
Press spacebar to pause and continue. Press esc to stop.